When THC attaches to the receptor, the effect is like an off switch to a light bulb, effectively turning "off" the pain. But ...

Vertex has gained the FDA's approval for its nonaddictive pain med Journavx, which becomes the first significant innovation ...

The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...

Vertex Pharmaceuticals on Thursday won approval from the Food and Drug Administration for a non-opioid pain drug, clearing ...

The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...

The stress level remains high for some. There are more and more people who are experiencing not just back pains but also frequent headaches. To be able to identify the different types of headaches ...

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...

The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...

Newborns can experience headaches, reflected in continuous crying, feeding issues, and sleep changes. It can be challenging for caregivers to identify headaches in newborns due to their inability ...

June 26, 2024 — A drug used to prevent migraine may also be effective in people with migraine who experience rebound headaches, according to a new ... Use of Acid Reflux Drugs Linked to Higher ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...